Frequent copy number gain of MCL1 is a therapeutic target for osteosarcoma.
Takagi S, Nakajima M, Koike S, Takami M, Sugiura Y, Sakata S, Baba S, Takemoto A, Huang T, Seto Y, Saito M, Funauchi Y, Ae K, Takeuchi K, Fujita N, Katayama R.
Takagi S, et al. Among authors: sugiura y.
Oncogene. 2024 Dec 11. doi: 10.1038/s41388-024-03251-6. Online ahead of print.
Oncogene. 2024.
PMID: 39663392